Press Releases

Leukocare announces new management structure to support global set-up and accelerate growth

Leukocare appoints Professor Bernhardt L. Trout to the Scientific Advisory Board

Dr. Dirk Winnemöller joins Leukocare as Vice President Commercial

Leukocare Strengthens Intellectual Property Portfolio on Virus Formulations in the US

Dr. Cornelius Pompe joined Leukocare as Vice President R&D; Dr. Sabine Hauck appointed as Senior Vice President Corporate Development

Strong growth: Leukocare moves into new headquarters at the Innovation and Start-up Center for Biotechnology (IZB) in Martinsried/Planegg

Auf Wachstumskurs: Leukocare bezieht neuen Firmenstandort am Innovations- und Gründungszentrum Biotechnologie (IZB) in Martinsried/Planegg

Leukocare Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities

Leukocare gibt Finanzierungsrunde in Höhe von 17,5 Mio. US-Dollar zum weiteren Ausbau des US-Geschäfts und der Bioinformatik-Aktivitäten bekannt

Leukocare cooperates with the Drug Safety Foundation and the Central Laboratory of German Pharmacists to investigate the stability of monoclonal antibodies during shipment and storage